Zydus Lifesciences announces WHO approval for NLRP3 inhibitor Usnoflast

Zydus Lifesciences, a discovery-based, global pharmaceutical leader, has recently received approval from the World Health Organization (WHO) International Non-proprietary Names (INN) for "Usnoflast" as the ... Read More